Skip to content

Extended Depth Of Focus (EDOF) contact lenses for myopia management in children

An investigation of myopia management using different types of Extended Depth of Focus (EDOF) contact lenses among myopic children in Malaysia

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000277347
Enrollment
240
Registered
2026-03-05
Start date
2026-04-01
Completion date
2027-09-30
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to evaluate the effectiveness of Extended Depth of Focus (EDOF) contact lenses in slowing the progression of myopia in children.Changes in cycloplegic refractive error, ocular dimensions, peripheral refraction, and choroidal thickness will be assessed to monitor myopia progression and structural eye changes. The primary hypothesis is that the use of EDOF contact lenses will be associated with a reduction in the rate of myopia progression compared with expected age-related progression. The results of this study may provide clinical evidence to support the use of EDOF contact lenses as a myopia control intervention in paediatric populations.

Interventions

The intervention in this study involves the use of Extended Depth of Focus (EDOF) contact lenses as an optical approach for myopia control in children. Participants will be fitted with soft EDOF contact lenses prescribed according to their individual refractive error to provide full distance vision correction while delivering a controlled peripheral defocus intended to slow myopia progression. The contact lenses will be fitted and reviewed by a qualified and registered optometrist with experienc

The intervention in this study involves the use of Extended Depth of Focus (EDOF) contact lenses as an optical approach for myopia control in children. Participants will be fitted with soft EDOF contact lenses prescribed according to their individual refractive error to provide full distance vision correction while delivering a controlled peripheral defocus intended to slow myopia progression. The contact lenses will be fitted and reviewed by a qualified and registered optometrist with experience in paediatric contact lens practice, in accordance with standard clinical fitting guidelines. This will be randomised, single-masked, controlled study. Two hundred and forty myopic children (240) will be divided into two groups. Group 1 (Low Myopia) consist of participants with refractive error range from -0.50DS to -4.75DS whereby Group 2 (High Myopia) consist of participants with refractive error range from -5.00DS to -8.00DS. In other words, the subjects are not randomised, but rather allocated based on their refractive error. Randomisation will occur when assigning the type of lens to be worn within each group. In both Group 1 and Group 2, each participant will be randomly assigned using an online randomiser to wear either Middle EDOF, High EDOF or Single Vision lens. Both EDOF types of lens will serve as experimental group while Single Vision lens will act as a control group. In summary, there will be six sub-groups listed below: • Group 1A – Low Myopia + Middle EDOF • Group 1B – Low Myopia + High EDOF • Group 1C – Low Myopia + Single Vision (control) • Group 2A – High Myopia + Middle EDOF • Group 2B – High Myopia + High EDOF • Group 2C – High Myopia + Single Vision (control) Participants and their parents or guardians will receive verbal and written instructions on correct contact lens insertion and removal, hygiene practices, daily wear schedule, and safe lens handling through handouts on their first visit. Participants will be instructed to wear the daily disposable EDOF contact lenses eight hours per day, at least five days a week. The intervention will be delivered through individual, face-to-face clinical visits conducted in an optometry clinic or university eye clinic setting and will continue over a follow-up period of 24 months, with scheduled review visits every six-month intervals (6, 12, 18 and 24 months) to investigate the changes of axial length elongation, spherical equivalent refraction, ocular dimension, binocular vision status, peripheral refraction, retinal and choroidal thickness. Virtual follow-ups will be conducted monthly to ensure participants' vision and comfort. Participants will undergo cycloplegic auto-refraction to ensure accurate assessment of refractive error. Cycloplegia will be induced using 1% cyclopentolate hydrochloride (Cyclogyl), which will be administered by trained clinical personnel according to standard clinical protocols. Cycloplegic refraction will be performed every six months over the 24-month study period. The study will be conducted under the supervision of a consultant ophthalmologist from Hospital Al-Sultan Abdullah (HASA), UiTM, who will be available for consultation and management in the event of any ocular complications or clinical emergencies arising during the study period. Appropriate referral pathways will be in place to ensure timely ophthalmological assessment and care when required.

Sponsors

SEED CONTACT LENS (MALAYSIA) SDN BHD
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
7 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

Subjects will only be eligible for the study if: - They are children between 7 to 15 years old. - They acquire refractive error (spherical equivalent) between -0.50D to -8.00D, with astigmatism less than -1.00DC - They achieve visual acuity of 6/6 monocularly and binocularly - The parent/guardian understand the rights of their child as a research subject and are willing to sign the consent form. - They are willing to sign the assent form after receiving approval from their parent/guardian - The children and their parent/guardian are willing and able to follow the study protocol. - They children and their parent/guardian agree not to participate in other clinical research for the duration of this study. - They can be satisfactorily fitted with the study lens types. - They are willing to comply with the lens wear schedule (at least five days per week and for at least eight hours per day).

Exclusion criteria

Subjects will not be eligible to take part in the study if: - They are currently or have had received any types of myopia control treatment. - They have an ocular disorder which would normally contra-indicate contact lens wear. - They have a systemic disorder which would normally contra-indicate contact lens wear. - They are using any topical medication such as eye drops or ointment. - They have had any types of ocular surgery (e.g. cataract, refractive). - They have any corneal distortion or have keratoconus. - They are currently on immunosuppressive medication. - They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear. - They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction. - They have taken part in any other contact lens or care solution clinical trial or research prior to starting this study.

Outcome results

None listed

Source: ANZCTR · Data processed: Apr 3, 2026